Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a suppository or a local block take the pain out of fertility testing?

NCT ID NCT07792668

Symptom relief Sponsor: Balikesir University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This trial tests two pain-relief options for hysterosalpingography (HSG), an X-ray test that checks the fallopian tubes and can be painful. Researchers will compare a rectal indomethacin suppository, a lidocaine injection around the cervix, and no pain medication in 180 women aged 18 to 45 who are having HSG as part of an infertility workup. The main question is whether either treatment lowers pain during the contrast injection, with secondary measures covering pain at other steps, anxiety, satisfaction, and side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Rectal indomethacin suppository or paracervical block with lidocaine, compared with no premedication
What this could lead to
If one of these pain-relief methods works well, it could make HSG, a common infertility test, much more comfortable for many women.
What could go wrong
This is a single trial with 180 participants, so results may not apply to everyone. Also, both treatments carry small risks, such as allergic reactions or discomfort from the block itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants aged 18 to 45 years * Scheduled for diagnostic hysterosalpingography as part of infertility evaluation * Able to understand the study procedures and provide written informed consent * Able to report pain intensity using a 0-to-10 Numeric Rating Scale * Hysterosalpingography scheduled during the appropriate menstrual-cycle period according to routine institutional practice * Pregnancy excluded before hysterosalpingography according to routine institutional practice Exclusion Criteria: * Pregnancy or suspected pregnancy * Active pelvic inflammatory disease or active genital tract infection * Known hypersensitivity or contraindication to indomethacin or other nonsteroidal anti-inflammatory drugs * Known hypersensitivity to lidocaine or other amide-type local anesthetics * Known hypersensitivity to the contrast medium used for hysterosalpingography * Active peptic ulcer disease or a history of clinically significant gastrointestinal bleeding * Significant renal or hepatic disease * Clinically significant bleeding disorder * Current anticoagulant therapy * Use of systemic analgesic, sedative, or antispasmodic medication within the predefined period before hysterosalpingography * Chronic pelvic pain requiring regular analgesic treatment * Severe dysmenorrhea requiring regular analgesic treatment * Cervical stenosis requiring anesthesia for hysterosalpingography Inability to provide reliable pain scores

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hysterosalpingography-related pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder Pain, Procedural

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hysterosalpingography-related pain Infertility

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.